Research suggests cannabis use may impact sperm count, motility, morphology, and overall …
#35 Clinical Context
Background information relevant to the evolving cannabis medicine landscape.
Clinicians should counsel male patients planning pregnancy that cannabis use may impair sperm parameters including count, motility, and morphology, potentially reducing fertility outcomes. This evidence is particularly relevant for reproductive medicine specialists and primary care providers discussing family planning with male patients. Patients seeking fertility treatment should be informed about cannabis’s potential impact on semen quality so they can make informed decisions about use before conception.
Recent evidence indicates that cannabis use may adversely affect male fertility parameters including sperm count, motility, and morphology, with a 2024 case-control study of IVF patients providing robust data supporting this association. These findings are particularly relevant for clinicians counseling male patients of reproductive age who are using or considering cannabis, as the effects on spermatogenesis could impact fertility outcomes and family planning timelines. The mechanisms underlying these reproductive effects likely involve cannabinoid-mediated disruption of endocrine signaling and testicular function, though further research is needed to establish dose-response relationships and reversibility following cessation. Clinicians should incorporate reproductive history and fertility goals into cannabis risk-benefit discussions with male patients, especially those presenting with infertility or planning conception. Male patients using cannabis who are experiencing difficulty conceiving should be counseled about potential fertility impacts and offered reproductive assessment. Practitioners caring for couples pursuing assisted reproductive technologies should specifically screen male partners for cannabis use and discuss the potential implications for treatment success.
“We have sufficient evidence now that cannabis use meaningfully affects male fertility parameters, and I counsel patients planning conception that stopping use several months before attempting pregnancy gives them the best chance of success, particularly when morphology or motility are already borderline concerns.”
🧬 Emerging evidence from controlled studies suggests that cannabis use may adversely affect multiple parameters of male fertility, including sperm count, motility, and morphology, which warrants clinical attention given the increasing prevalence of cannabis use among reproductive-age men. However, several important confounders limit current interpretability: most studies are observational or involve small sample sizes, the dose-response relationship remains unclear, duration and recency of use are often poorly characterized, and cannabis products vary widely in cannabinoid composition and route of administration. Additionally, many men using cannabis concurrently use tobacco, alcohol, or other substances that independently affect spermatogenesis, making it difficult to isolate cannabis’s specific contribution. Given these uncertainties, clinicians should consider obtaining a detailed cannabis use history as part of routine fertility counseling for couples with male factor infertility or unexplained subfertility, and may counsel men with fertility concerns that current evidence suggests potential
This topic comes up in consultations often.
Dr. Caplan offers clinical context on evolving cannabis policy and its real-world implications for patients.
Book a consultation →💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
